

share
Clindamycin B Palmitate CAS NO 68206-99-5
Unit Price:
CAS No.:68206-99-5
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Clindamycin B Palmitate CAS NO 68206-99-5 is a chemically modified derivative of the lincosamide antibiotic clindamycin, designed to enhance stability and bioavailability. This palmitate ester form is a critical intermediate in the synthesis of pharmaceutical formulations, offering improved handling characteristics for industrial-scale production. It is primarily utilized by manufacturers in the pharmaceutical and biotechnology sectors for the development of antibiotic therapies.
Application
- Active Pharmaceutical Ingredient (API) Intermediate: A key starting material in the synthesis of finished clindamycin antibiotic formulations.
- Pharmaceutical Research & Development: Used in preclinical and clinical studies to develop new antibiotic delivery systems and dosage forms.
- Veterinary Medicine Production: Employed in the manufacture of antibiotic treatments for bacterial infections in animals.
- Prodrug Synthesis: Serves as a prodrug precursor, where enzymatic cleavage in the body releases the active clindamycin moiety.
- Formulation Excipient: Can be used to modify the solubility and release profile of antibiotic preparations.
Basic Information
| Product Name | Clindamycin B Palmitate |
| CAS No. | 68206-99-5 |
| Molecular Formula | C34H63ClN2O6S |
| Molecular Weight | 663.40 g/mol |
| Synonyms | Clindamycin B Palmitate; Clindamycin Palmitate B; (2S,4R)-N-[(1S,2S)-2-Chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide hexadecanoate; Palmitic acid clindamycin B ester; U-28508; Antibiotic U-28508; Lincosamide antibiotic ester |
| EINECS | Contact for details |
Quality Control
Our Clindamycin B Palmitate is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including identification, purity assay, and impurity profiling, to ensure it meets stringent specifications suitable for pharmaceutical use. Certificates of Analysis (COA) documenting compliance with relevant standards are provided with every shipment.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed to prevent moisture absorption, which can affect stability and potency.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white powder |
| Identification (IR) | Conforms to reference spectrum |
| Assay (HPLC) | ≥ 98.0% |
| Related Substances (HPLC) | Total impurities ≤ 2.0% |
| Water Content (KF) | ≤ 2.0% |
| Residue on Ignition | ≤ 0.1% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Clindamycin CAS NO 18323-44-9


Lincomycin CAS NO 154-21-2


Lincomycin B Hydrochloride CAS NO 11021-35-5


Lincosamine CAS NO 13006-69-4


Lincomycin Hydrochloride CAS NO 17017-22-0


7-Chlorolincomycin Hydrochloride CAS NO 17431-55-9


Clindamycin B CAS NO 18323-43-8


Paldimycin CAS NO 102426-96-0


Aladapcin CAS NO 114540-27-1


Linnocuicina 819 CAS NO 117742-82-2


R: Cl CAS NO 128092-74-0


1-n-Cbz-3-Pyrrolidinone CAS NO 130312-02-6


L-Proline, 1-Phenyl-5-Thioxo-, Methyl Ester (9Ci) CAS NO 146500-36-9


Chloramlincomycin CAS NO 148077-14-9


Sparsolincomycin CAS NO 148077-15-0


Desotamide CAS NO 194660-14-5


Clindamycin Myristate CAS NO 1123211-66-4


Clindamycin Pentadecanoate CAS NO 1123211-67-5


Clindamycin Heptadecanoate CAS NO 1123211-69-7


Clindamycin Stearate CAS NO 1123211-70-0
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






